Search

Context. Studies investigating the association between serum IGF-1, and thyroid nodule, ovarian or thyroid volume in polycystic ovarian syndrome (PCOS) are limited. Objective. We aimed to analyze the association between serum IGF-1 level, and ovarian or thyroid volume, or thyroid nodule in PCOS. Design. The study was performed between June 2017 and August 2019 as prospective design. Subjects and methods. Adult females with newonset PCOS were included. The patients having comorbid illness, or using medication were excluded. Basic tests, thyroid and ovarian sonography were performed. The patients were grouped according to thyroid nodule(absent/present) and ovarian volume (<10mL/=10mL). We planned to find a positive association between IGF-1, and thyroid nodule, thyroid or ovarian volume in PCOS. Results. Of total 118 patients, 11(9%) had thyroid nodule. The patients with thyroid nodule had a higher ovarian volume (p=0.006). No correlation was found between GH or IGF-1, and thyroid or ovarian volume. IGF-1 was not a predictor for thyroid nodule or higher ovarian volume. Thyroid nodule was a significant predictor for higher ovarian volume. Conclusion. Our study is the first to analyze the association between IGF-1 and thyroid nodule in PCOS. We found that thyroid nodule was associated with thyroid and ovarian volume, but IGF-1 was not associated with thyroid nodule, thyroid or ovarian volume. [ABSTRACT FROM AUTHOR]

To examine trends in morbidity, hospital length and cost of stay in UF patients with low and high comorbidity index. Conclusions UF patients with high comorbidity index incur significantly longer hospital length of stay and nearly three more costs compared to patients with low comorbidity index. [Extracted from the article]

To examine trends in mortality, morbidity, hospital length and cost of stay in PID patients with low and high comorbidity index. Conclusions PID patients with high comorbidity index incur significantly longer hospital length of stay and more than 2 times the costs and 3 times the mortality compared to patients with low comorbidity index. [Extracted from the article]

To examine trends in morbidity, hospital length and cost of stay in narcolepsy patients with low and high comorbidity index. Conclusions Narcolepsy patients with high comorbidity index incur significantly longer hospital length of stay and nearly 50% more costs compared to patients with low comorbidity index. [Extracted from the article]

To examine trends in mortality, morbidity, hospital length and cost of stay in influenza patients with low and high comorbidity index. Conclusions Influenza patients with high comorbidity index incur significantly longer hospital length of stay and nearly 3 times the costs and mortality compared to patients with low comorbidity index. [Extracted from the article]